Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Pfizer
EXACT Therapeutics AS
Pfizer
Corcept Therapeutics
Institut Curie
Pfizer
Jacobio Pharmaceuticals Co., Ltd.
Revolution Medicines, Inc.
MacroGenics
Travera Inc
University Hospital Tuebingen
Corewell Health West
Allist Pharmaceuticals, Inc.
Allist Pharmaceuticals, Inc.
University Health Network, Toronto
Angiodynamics, Inc.
Revolution Medicines, Inc.
Ruijin Hospital
Peking Union Medical College Hospital
Sumitomo Pharma America, Inc.
University Hospital Plymouth NHS Trust
Sumitomo Pharma America, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
St. Olavs Hospital
Oryx GmbH & Co. KG
Hospital Universitari de Bellvitge
Instituto Ecuatoriano de Enfermedades Digestivas
Fudan University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
New York Presbyterian Brooklyn Methodist Hospital
AstraZeneca
Halozyme Therapeutics
Halozyme Therapeutics
Celgene
Rambam Health Care Campus
Fudan University
University of Roma La Sapienza
Precision Biologics, Inc
Astellas Pharma Inc
Massachusetts General Hospital
Radboud University Medical Center
Silence Therapeutics GmbH
University of Florida
Astellas Pharma Inc
Changhai Hospital
Shanghai Zhongshan Hospital
Mayo Clinic
Pfizer
Grupo Hospital de Madrid